These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 19997577)
1. Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting. Sharma RK; Reddy HK; Singh VN; Sharma R; Voelker DJ; Bhatt G Vasc Health Risk Manag; 2009; 5():965-72. PubMed ID: 19997577 [TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease: Platelet activity: an obstacle for successful PCI. Gawaz M; Geisler T Nat Rev Cardiol; 2009 Jun; 6(6):391-2. PubMed ID: 19471282 [TBL] [Abstract][Full Text] [Related]
3. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW; JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034 [TBL] [Abstract][Full Text] [Related]
4. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation. Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464 [TBL] [Abstract][Full Text] [Related]
5. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM; Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975 [TBL] [Abstract][Full Text] [Related]
6. Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity. Pant S; Neupane P; Ramesh KC; Barakoti M Cardiol J; 2011; 18(6):712-7. PubMed ID: 22113766 [TBL] [Abstract][Full Text] [Related]
7. Coronary artery stenting in patients treated by clopidogrel without aspirin. Rott D; Leibowitz D; Amit G; Zahger D; Weiss AT Int J Cardiol; 2009 Apr; 133(2):279-81. PubMed ID: 18178268 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
11. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903 [TBL] [Abstract][Full Text] [Related]
12. A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent. Arima M; Matsuda A; Nitta M; Yoshida K; Shimizu M Heart Vessels; 2012 Jan; 27(1):106-9. PubMed ID: 21445598 [TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]
14. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Zimarino M; Renda G; De Caterina R Drugs; 2005; 65(6):725-32. PubMed ID: 15819586 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818 [TBL] [Abstract][Full Text] [Related]